表紙
市場調查報告書

神經血管栓塞設備的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·預測 (2019∼2027年)

Neurovascular Embolization Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 920565
出版日期 內容資訊 英文 213 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經血管栓塞設備的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·預測 (2019∼2027年) Neurovascular Embolization Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年10月24日內容資訊: 英文 213 Pages
簡介

本報告提供全球神經血管栓塞設備的市場相關分析,提供市場基本結構和主要的影響要素,市場規模趨勢預測 (過去2年·今後9年份),各產品·治療內容·不同症狀·各終端用戶及地區別·主要國家詳細趨勢,競爭環境 (市場佔有率結構),主要企業簡介等調查。

第1章 序論

第2章 前提條件·分析方法

第3章 摘要整理:全球神經血管栓塞設備市場

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 市場分析與預測 (總計11年份)
    • 市場規模的預測 (以金額為準)

第5章 市場展望

  • 產業的主要趨勢
  • 法規方案
  • 醫療費償付方案
  • 主要的企業合併·收購 (M&A)
  • 技術進步

第6章 全球神經血管栓塞設備市場預測:各產品

  • 簡介·定義
  • 市場規模的預測:各產品 (以金額為準,總計11年份)
    • 栓塞線圈
    • 液體栓塞劑
    • 血流支流用支架
    • 動脈瘤夾
    • 其他
  • 市場向心力:各產品

第7章 全球神經血管栓塞設備市場預測:各治療內容

  • 簡介·定義
  • 市場規模的預測:各治療內容 (以金額為準,總計11年份)
    • 缺血性發作
    • 出血性發作
  • 市場向心力:各治療內容

第8章 全球神經血管栓塞設備市場預測:不同症狀

  • 簡介·定義
  • 市場規模的預測:不同症狀 (以金額為準,總計11年份)
    • 腦動脈瘤
    • 動靜脈畸形 (AVM)
    • 其他
  • 市場向心力:不同症狀

第9章 全球神經血管栓塞設備市場預測:各終端用戶

  • 簡介
  • 市場規模的預測:各終端用戶 (以金額為準,總計11年份)
    • 醫院
    • 當天返回手術中心 (ASC)
    • 專門診所
  • 市場向心力:各終端用戶

第10章 全球神經血管栓塞設備市場預測:各地區

  • 簡介·定義
  • 市場規模的預測:各地區 (以金額為準,總計11年份)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場向心力:各地區

第10章 北美的管制藥物市場分析與預測

  • 簡介
  • 市場規模的預測:各產品 (以金額為準,總計11年份)
  • 市場規模的預測:各治療內容 (以金額為準,總計11年份)
  • 市場規模的預測:不同症狀 (以金額為準,總計11年份)
  • 市場規模的預測:各終端用戶 (以金額為準,總計11年份)
  • 市場規模的預測:各國各地區 (以金額為準,總計11年份)
    • 美國,加拿大
  • 市場向心力分析:各產品·治療內容·不同症狀·各終端用戶·各國

第12章 歐洲的管制藥物市場分析與預測

  • 市場規模的預測:各國各地區 (以金額為準,總計11年份)
    • 德國,英國,法國,西班牙,義大利等

第13章 亞太地區的管制藥物市場分析與預測

  • 市場規模的預測:各國各地區 (以金額為準,總計11年份)
    • 日本,中國,印度,澳洲·紐西蘭等

第14章 南美的管制藥物市場分析與預測

  • 市場規模的預測:各國各地區 (以金額為準,總計11年份)
    • 巴西,墨西哥等

第15章 中東·非洲的管制藥物市場分析與預測

  • 市場規模的預測:各國各地區 (以金額為準,總計11年份)
    • 波灣合作理事會 (GCC) 各國,南非等

第16章 競爭環境

  • 市場佔有率分析:各企業
  • 企業簡介
    • Medtronic plc
      • 企業概要
      • 事業概要
      • 主要的財務指標
      • 策略概要
      • SWOT分析
    • Stryker Corporation
    • DePuy Synthes (Johnson & Johnson Services, Inc.)
    • B.Braun Melsungen AG
    • Penumbra, Inc.
    • Acandis GmbH
    • BALT EXTRUSION
    • Terumo Corporation
    • Boston Scientific Corporation
    • Spartan Micro, Inc.
目錄

Scope of the Report

TMR's report on the global neurovascular embolization devices (neurology) market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global neurovascular embolization devices (neurology) market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global neurovascular embolization devices (neurology) market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents, to understand the global neurovascular embolization devices (neurology) market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global neurovascular embolization devices (neurology) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global neurovascular embolization devices (neurology) market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global neurovascular embolization devices (neurology) market. The next section of the global neurovascular embolization devices (neurology) report highlights the USPs, which include the regulatory scenario, reimbursement scenario, key mergers & acquisitions, technological advancements, and key industry developments in the global neurovascular embolization devices (neurology) market.

The report delves into the competitive landscape of the global neurovascular embolization devices (neurology) market. Key players operating in the global neurovascular embolization devices (neurology) market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global neurovascular embolization devices (neurology) market profiled in this report.

Key Questions Answered:

  • What are the major drivers, restraints, opportunities in the market?
  • What are the revenue share projections of key segments in the global neurovascular embolization devices (neurology) market for the forecast period?
  • Which segment is likely to lead the neurovascular embolization devices (neurology) market in terms of revenue by 2027?
  • How are mergers & acquisitions among players widening the scope of the neuroendovascular embolization devices (neurology) market?
  • What is the market position of different companies operating in the global neurovascular embolization devices (neurology) market?

Research Methodology

The comprehensive report on the global neurovascular embolization devices (neurology) market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the global neurovascular embolization devices (neurology) market. It is followed by a market introduction, market dynamics, and an overview of the global neurovascular embolization devices (neurology) market, which includes TMR's analysis of the market drivers, restraints, and trends affecting the growth of the global neurovascular embolization devices (neurology) market. Furthermore, to understand the Y-o-Y trends of the neurovascular embolization devices (neurology) market, a Y-o-Y analysis with elaborated insights on the same have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Key Industry Developments
  • 5.2. Regulatory Scenario
  • 5.3. Reimbursement Scenario
  • 5.4. Key Mergers & Acquisitions
  • 5.5. Technological Advancements

6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017-2027
    • 6.2.1. Embolization Coils
    • 6.2.2. Liquid Embolic Systems
    • 6.2.3. Flow Diversion Stents
    • 6.2.4. Aneurysm Clips
    • 6.2.5. Others
  • 6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product

7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017-2027
    • 7.2.1. Ischemic Stroke Solution
    • 7.2.2. Hemorrhagic Stroke Solution
  • 7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment

8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication

  • 8.1. Introduction
  • 8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017-2027
    • 8.2.1. Brain Aneurysms
    • 8.2.2. Arteriovenous Malformation (AVM)
    • 8.2.3. Others
  • 8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication

9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User

  • 9.1. Introduction
  • 9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017-2027
    • 9.2.1. Hospitals
    • 9.2.2. Ambulatory Surgery Centers
    • 9.2.3. Specialty Clinics
  • 9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User

10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region

  • 10.1. Introduction
  • 10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017-2027
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region

11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017-2027
    • 11.2.1. Embolization Coils
    • 11.2.2. Liquid Embolic Systems
    • 11.2.3. Flow Diversion Stents
    • 11.2.4. Aneurysm Clips
    • 11.2.5. Others
  • 11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017-2027
    • 11.3.1. Ischemic Stroke Solution
    • 11.3.2. Hemorrhagic Stroke Solution
  • 11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017-2027
    • 11.4.1. Brain Aneurysms
    • 11.4.2. Arteriovenous Malformation (AVM)
    • 11.4.3. Others
  • 11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017-2027
    • 11.5.1. Hospitals
    • 11.5.2. Ambulatory Surgery Centers
    • 11.5.3. Specialty Clinics
  • 11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017-2027
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Treatment
    • 11.7.3. By Indication
    • 11.7.4. By End User
    • 11.7.5. By Country/Sub-region

12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017-2027
    • 12.2.1. Embolization Coils
    • 12.2.2. Liquid Embolic Systems
    • 12.2.3. Flow Diversion Stents
    • 12.2.4. Aneurysm Clips
    • 12.2.5. Others
  • 12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017-2027
    • 12.3.1. Ischemic Stroke Solution
    • 12.3.2. Hemorrhagic Stroke Solution
  • 12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017-2027
    • 12.4.1. Brain Aneurysms
    • 12.4.2. Arteriovenous Malformation (AVM)
    • 12.4.3. Others
  • 12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017-2027
    • 12.5.1. Hospitals
    • 12.5.2. Ambulatory Surgery Centers
    • 12.5.3. Specialty Clinics
  • 12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017-2027
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Treatment
    • 12.7.3. By Indication
    • 12.7.4. By End User
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017-2027
    • 13.2.1. Embolization Coils
    • 13.2.2. Liquid Embolic Systems
    • 13.2.3. Flow Diversion Stents
    • 13.2.4. Aneurysm Clips
    • 13.2.5. Others
  • 13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017-2027
    • 13.3.1. Ischemic Stroke Solution
    • 13.3.2. Hemorrhagic Stroke Solution
  • 13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017-2027
    • 13.4.1. Brain Aneurysms
    • 13.4.2. Arteriovenous Malformation (AVM)
    • 13.4.3. Others
  • 13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017-2027
    • 13.5.1. Hospitals
    • 13.5.2. Ambulatory Surgery Centers
    • 13.5.3. Specialty Clinics
  • 13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017-2027
    • 13.6.1. Japan
    • 13.6.2. China
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Treatment
    • 13.7.3. By Indication
    • 13.7.4. By End User
    • 13.7.5. By Country/Sub-region

14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017-2027
    • 14.2.1. Embolization Coils
    • 14.2.2. Liquid Embolic Systems
    • 14.2.3. Flow Diversion Stents
    • 14.2.4. Aneurysm Clips
    • 14.2.5. Others
  • 14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017-2027
    • 14.3.1. Ischemic Stroke Solution
    • 14.3.2. Hemorrhagic Stroke Solution
  • 14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017-2027
    • 14.4.1. Brain Aneurysms
    • 14.4.2. Arteriovenous Malformation (AVM)
    • 14.4.3. Others
  • 14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017-2027
    • 14.5.1. Hospitals
    • 14.5.2. Ambulatory Surgery Centers
    • 14.5.3. Specialty Clinics
  • 14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017-2027
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Treatment
    • 14.7.3. By Indication
    • 14.7.4. By End User
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

  • 15.1. Introduction
  • 15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017-2027
    • 15.2.1. Embolization Coils
    • 15.2.2. Liquid Embolic Systems
    • 15.2.3. Flow Diversion Stents
    • 15.2.4. Aneurysm Clips
    • 15.2.5. Others
  • 15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017-2027
    • 15.3.1. Ischemic Stroke Solution
    • 15.3.2. Hemorrhagic Stroke Solution
  • 15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017-2027
    • 15.4.1. Brain Aneurysms
    • 15.4.2. Arteriovenous Malformation (AVM)
    • 15.4.3. Others
  • 15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017-2027
    • 15.5.1. Hospitals
    • 15.5.2. Ambulatory Surgery Centers
    • 15.5.3. Specialty Clinics
  • 15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017-2027
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Treatment
    • 15.7.3. By Indication
    • 15.7.4. By End User
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)
  • 16.2. Company Profiles
    • 16.2.1. Medtronic plc
      • 16.2.1.1. Company Description
      • 16.2.1.2. Business Overview
      • 16.2.1.3. Financial Overview
      • 16.2.1.4. Strategic Overview
      • 16.2.1.5. SWOT Analysis
    • 16.2.2. Stryker Corporation
      • 16.2.2.1. Company Description
      • 16.2.2.2. Business Overview
      • 16.2.2.3. Financial Overview
      • 16.2.2.4. Strategic Overview
      • 16.2.2.5. SWOT Analysis
    • 16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)
      • 16.2.3.1. Company Description
      • 16.2.3.2. Business Overview
      • 16.2.3.3. Financial Overview
      • 16.2.3.4. Strategic Overview
      • 16.2.3.5. SWOT Analysis
    • 16.2.4. B.Braun Melsungen AG
      • 16.2.4.1. Company Description
      • 16.2.4.2. Business Overview
      • 16.2.4.3. Financial Overview
      • 16.2.4.4. Strategic Overview
      • 16.2.4.5. SWOT Analysis
    • 16.2.5. Penumbra, Inc.
      • 16.2.5.1. Company Description
      • 16.2.5.2. Business Overview
      • 16.2.5.3. Financial Overview
      • 16.2.5.4. Strategic Overview
      • 16.2.5.5. SWOT Analysis
    • 16.2.6. Acandis GmbH
      • 16.2.6.1. Company Description
      • 16.2.6.2. Business Overview
      • 16.2.6.3. Financial Overview
      • 16.2.6.4. Strategic Overview
      • 16.2.6.5. SWOT Analysis
    • 16.2.7. BALT EXTRUSION
      • 16.2.7.1. Company Description
      • 16.2.7.2. Business Overview
      • 16.2.7.3. Financial Overview
      • 16.2.7.4. Strategic Overview
      • 16.2.7.5. SWOT Analysis
    • 16.2.8. Terumo Medical Corporation
      • 16.2.8.1. Company Description
      • 16.2.8.2. Business Overview
      • 16.2.8.3. Financial Overview
      • 16.2.8.4. Strategic Overview
      • 16.2.8.5. SWOT Analysis
    • 16.2.9. Boston Scientific Corporation
      • 16.2.9.1. Company Description
      • 16.2.9.2. Business Overview
      • 16.2.9.3. Financial Overview
      • 16.2.9.4. Strategic Overview
      • 16.2.9.5. SWOT Analysis
    • 16.2.10. Spartan Micro, Inc.
      • 16.2.10.1. Company Description
      • 16.2.10.2. Business Overview
      • 16.2.10.3. Financial Overview
      • 16.2.10.4. Strategic Overview
      • 16.2.10.5. SWOT Analysis

List of Tables

  • Table 01: Hospital Inpatient Billing and Payment Reimbursement Scenario
  • Table 02: Physician Billing and Payment for Reimbursement
  • Table 03: Key Mergers and Acquisitions
  • Table 04: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 05: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 07: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 08: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 09: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 10: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 11: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
  • Table 12: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
  • Table 13: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
  • Table 14: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 15: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 16: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
  • Table 17: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
  • Table 18: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
  • Table 19: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 20: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 21: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
  • Table 22: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
  • Table 23: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
  • Table 24: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 25: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 26: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
  • Table 27: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
  • Table 28: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
  • Table 29: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 30: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 31: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
  • Table 32: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
  • Table 33: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

List of Figures

  • Figure 01: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Distribution (%), by Region, 2019 and 2027
  • Figure 02: Neurovascular Embolization Devices (Neurology) Market - Key Industry Developments
  • Figure 03: Market Drivers
  • Figure 04: Market Restraints
  • Figure 05: Key Opportunities
  • Figure 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 07: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product (2018)
  • Figure 08: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment (2018)
  • Figure 09: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication (2018)
  • Figure 10: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User (2018)
  • Figure 11: Europe Regulatory Approval Process
  • Figure 12: Technological Advancements
  • Figure 13: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
  • Figure 14: Global Neurovascular Embolization Devices Neurology) Market Attractiveness, by Product, 2019-2027
  • Figure 15: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Embolization Coils, 2017-2027
  • Figure 16: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liquid Embolic Systems, 2017-2027
  • Figure 17: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Diversion Stents, 2017-2027
  • Figure 18: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aneurysm Clips, 2017-2027
  • Figure 19: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 20: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
  • Figure 21: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019-2027
  • Figure 22: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrhagic Stroke Solution, 2017-2027
  • Figure 23: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ischemic Stroke Solution, 2017-2027
  • Figure 24: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
  • Figure 25: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019-2027
  • Figure 26: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain Aneurysms, 2017-2027
  • Figure 27: Global Ne Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arteriovenous Malformations (AVMs), 2017-2027
  • Figure 28: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 29: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
  • Figure 30: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019-2027
  • Figure 31: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2027
  • Figure 32: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017-2027
  • Figure 33: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017-2027
  • Figure 34: Global Neurovascular Embolization Devices (Neurology) Market: Regional Outlook
  • Figure 35: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Region, 2018 and 2027
  • Figure 36: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 37: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 38: North America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 39: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 40: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
  • Figure 41: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019-2027
  • Figure 42: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
  • Figure 43: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019-2027
  • Figure 44: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
  • Figure 45: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019-2027
  • Figure 46: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
  • Figure 47: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019-2027
  • Figure 48: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 49: Europe Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 50: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 51: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
  • Figure 52: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019-2027
  • Figure 53: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
  • Figure 54: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019-2027
  • Figure 55: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
  • Figure 56: Europe N Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019-2027
  • Figure 57: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
  • Figure 58: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019-2027
  • Figure 59: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 60: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 61: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 62: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
  • Figure 63: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019-2027
  • Figure 64: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
  • Figure 65: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019-2027
  • Figure 66: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
  • Figure 67: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019-2027
  • Figure 68: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
  • Figure 69: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019-2027
  • Figure 70: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 71: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 72: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 73: Latin Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
  • Figure 74: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019-2027
  • Figure 75: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
  • Figure 76: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019-2027
  • Figure 77: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
  • Figure 78: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019-2027
  • Figure 79: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
  • Figure 80: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019-2027
  • Figure 81: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 82: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 83: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 84: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
  • Figure 85: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019-2027
  • Figure 86: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
  • Figure 87: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019-2027
  • Figure 88: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
  • Figure 89: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019-2027
  • Figure 90: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
  • Figure 91: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019-2027
  • Figure 92: Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)
Back to Top